1. Home
  2. FATE vs CTGO Comparison

FATE vs CTGO Comparison

Compare FATE & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • CTGO
  • Stock Information
  • Founded
  • FATE 2007
  • CTGO 2009
  • Country
  • FATE United States
  • CTGO United States
  • Employees
  • FATE N/A
  • CTGO N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • CTGO Precious Metals
  • Sector
  • FATE Health Care
  • CTGO Basic Materials
  • Exchange
  • FATE Nasdaq
  • CTGO Nasdaq
  • Market Cap
  • FATE 177.7M
  • CTGO 151.1M
  • IPO Year
  • FATE 2013
  • CTGO N/A
  • Fundamental
  • Price
  • FATE $1.14
  • CTGO $20.18
  • Analyst Decision
  • FATE Hold
  • CTGO Strong Buy
  • Analyst Count
  • FATE 7
  • CTGO 1
  • Target Price
  • FATE $3.83
  • CTGO $37.00
  • AVG Volume (30 Days)
  • FATE 1.9M
  • CTGO 85.1K
  • Earning Date
  • FATE 08-12-2025
  • CTGO 08-13-2025
  • Dividend Yield
  • FATE N/A
  • CTGO N/A
  • EPS Growth
  • FATE N/A
  • CTGO N/A
  • EPS
  • FATE N/A
  • CTGO N/A
  • Revenue
  • FATE $13,335,000.00
  • CTGO N/A
  • Revenue This Year
  • FATE N/A
  • CTGO N/A
  • Revenue Next Year
  • FATE N/A
  • CTGO N/A
  • P/E Ratio
  • FATE N/A
  • CTGO N/A
  • Revenue Growth
  • FATE 105.85
  • CTGO N/A
  • 52 Week Low
  • FATE $0.66
  • CTGO $8.85
  • 52 Week High
  • FATE $5.92
  • CTGO $23.95
  • Technical
  • Relative Strength Index (RSI)
  • FATE 46.69
  • CTGO 54.37
  • Support Level
  • FATE $1.05
  • CTGO $19.05
  • Resistance Level
  • FATE $1.18
  • CTGO $20.52
  • Average True Range (ATR)
  • FATE 0.08
  • CTGO 0.96
  • MACD
  • FATE -0.00
  • CTGO -0.20
  • Stochastic Oscillator
  • FATE 54.76
  • CTGO 56.23

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.

Share on Social Networks: